Reference ranges for blood tests explained
Reference ranges (reference intervals) for blood tests are sets of values used by a health professional to interpret a set of medical test results from blood samples. Reference ranges for blood tests are studied within the field of clinical chemistry (also known as "clinical biochemistry", "chemical pathology" or "pure blood chemistry"), the area of pathology that is generally concerned with analysis of bodily fluids.
Blood test results should always be interpreted using the reference range provided by the laboratory that performed the test.[1]
Interpretation
A reference range is usually defined as the set of values 95 percent of the normal population falls within (that is, 95% prediction interval).[2] It is determined by collecting data from vast numbers of laboratory tests.
Plasma or whole blood
In this article, all values (except the ones listed below) denote blood plasma concentration, which is approximately 60–100% larger than the actual blood concentration if the amount inside red blood cells (RBCs) is negligible. The precise factor depends on hematocrit as well as amount inside RBCs. Exceptions are mainly those values that denote total blood concentration, and in this article they are:[3]
- All values in Hematology – red blood cells (except hemoglobin in plasma)
- All values in Hematology – white blood cells
- Platelet count (Plt)
A few values are for inside red blood cells only:
- Vitamin B9 (folic acid/folate) in red blood cells
- Mean corpuscular hemoglobin concentration (MCHC)
Units
Arterial or venous
If not otherwise specified, a reference range for a blood test is generally the venous range, as the standard process of obtaining a sample is by venipuncture. An exception is for acid–base and blood gases, which are generally given for arterial blood.
Still, the blood values are approximately equal between the arterial and venous sides for most substances, with the exception of acid–base, blood gases and drugs (used in therapeutic drug monitoring (TDM) assays).[5] Arterial levels for drugs are generally higher than venous levels because of extraction while passing through tissues.[5]
Usual or optimal
Reference ranges are usually given as what are the usual (or normal) values found in the population, more specifically the prediction interval that 95% of the population fall into. This may also be called standard range. In contrast, optimal (health) range or therapeutic target is a reference range or limit that is based on concentrations or levels that are associated with optimal health or minimal risk of related complications and diseases. For most substances presented, the optimal levels are the ones normally found in the population as well. More specifically, optimal levels are generally close to a central tendency of the values found in the population. However, usual and optimal levels may differ substantially, most notably among vitamins and blood lipids, so these tables give limits on both standard and optimal (or target) ranges. In addition, some values, including troponin I and brain natriuretic peptide, are given as the estimated appropriate cutoffs to distinguish healthy people from people with specific conditions, which here are myocardial infarction and congestive heart failure, respectively, for the aforementioned substances.
Variability
References range may vary with age, sex, race, pregnancy,[6] diet, use of prescribed or herbal drugs and stress. Reference ranges often depend on the analytical method used, for reasons such as inaccuracy, lack of standardisation, lack of certified reference material and differing antibody reactivity.[7] Also, reference ranges may be inaccurate when the reference groups used to establish the ranges are small.[8]
Sorted by concentration
By mass and molarity
Smaller, narrower boxes indicate a more tight homeostatic regulation when measured as standard "usual" reference range.
Hormones predominate at the left part of the scale, shown with a red at ng/L or pmol/L, being in very low concentration. There appears to be the greatest cluster of substances in the yellow part (μg/L or nmol/L), becoming sparser in the green part (mg/L or μmol/L). However, there is another cluster containing many metabolic substances like cholesterol and glucose at the limit with the blue part (g/L or mmol/L).
The unit conversions of substance concentrations from the molar to the mass concentration scale above are made as follows:
molarconcentration x molarmass=massconcentration
- Measured directly in distance on the scales:
log10
=distancetoright(decades)
,where distance is the direct (not logarithmic) distance in number of
decades or "octaves" to the right the mass concentration is found. To translate from mass to molar concentration, the dividend (
molar mass and the divisor (1000) in the
division change places, or, alternatively,
distance to right is changed to
distance to left. Substances with a molar mass around 1000g/mol (e.g. thyroxine) are almost vertically aligned in the mass and molar images. Adrenocorticotropic hormone, on the other hand, with a molar mass of 4540,
[9] is 0.7 decades to the right in the mass image. Substances with molar mass below 1000g/mol (e.g. electrolytes and metabolites) would have "negative" distance, that is, masses deviating to the left.Many substances given in mass concentration are not given in molar amount because they haven't been added to the article.
The diagram above can also be used as an alternative way to convert any substance concentration (not only the normal or optimal ones) from molar to mass units and vice versa for those substances appearing in both scales, by measuring how much they are horizontally displaced from one another (representing the molar mass for that substance), and using the same distance from the concentration to be converted to determine the equivalent concentration in terms of the other unit. For example, on a certain monitor, the horizontal distance between the upper limits for parathyroid hormone in pmol/L and pg/mL may be 7 cm, with the mass concentration to the right. A molar concentration of, for example, 5 pmol/L would therefore correspond to a mass concentration located 7 cm to the right in the mass diagram, that is, approximately 45 pg/mL.
By units
Units do not necessarily imply anything about molarity or mass.
A few substances are below this main interval, e.g. thyroid stimulating hormone, being measured in mU/L, or above, like rheumatoid factor and CA19-9, being measured in U/mL.
White blood cells
Sorted by category
Ions and trace metals
Included here are also related binding proteins, like ferritin and transferrin for iron, and ceruloplasmin for copper.
Test | Lower limit | Upper limit | Unit* | Comments | - | Sodium (Na) | 135, 137 | 145, 147 | mmol/L or mEq/L | | - | 310,[10] 320 | 330, 340 | mg/dL | - | - | Potassium (K) | 3.5, 3.6 | 5.0, 5.1 | mmol/L or mEq/L | | - | 14[11] | 20 | mg/dL | - | - | Chloride (Cl) | 95, 98, 100 | 105, 106, 110 | mmol/L or mEq/L | | - | 340[12] | 370 | mg/dL | - | - | Ionized calcium (Ca) | 1.03,[13] 1.10 | 1.23, 1.30 | mmol/L | | - | - | 4.1,[14] 4.4 | 4.9, 5.2 | mg/dL | - | - | Total calcium (Ca) | 2.1,[15] 2.2 | 2.5, 2.6, 2.8 | mmol/L | | - | - | 8.4, 8.5 | 10.2, 10.5 | mg/dL | | - | - | Total serum iron (TSI) – male | 65,[16] 76 | 176, 198 | μg/dL | | - | 11.6,[17] 13.6 | 30, 32, 35 | μmol/L | - | - | Total serum iron (TSI) – female | 26, 50 | 170 | μg/dL | | - | - | 4.6, 8.9 | 30.4 | μmol/L | | - | - | | 100 | 250 | μg/dL | | - | - | 18[18] | 45 | μmol/L | | - | - | Total serum iron (TSI) – children | 50 | 120 | μg/dL | | - | - | 9 | 21 | μmol/L | | - | - | Total iron-binding capacity (TIBC) | 240, 262 | 450, 474 | μg/dL | | - | - | 43, 47 | 81, 85 | μmol/L | | - | - | | 190,[19] 194, 204 | 326, 330, 360 | mg/dL | | - | 25[20] | 45 | μmol/L | | - | - | | 20 | 50 | % | | - | Ferritin – Males and postmenopausal females | 12[21] | 300[22] | ng/mL or μg/L | | - | 27[23] | 670 | pmol/L | | - | - | Ferritin – premenopausal females | 12 | 150 – 200 | ng/mL or μg/L | | - | 27 | 330 – 440 | pmol/L | | - | - | | 10,[24] 20[25] | 35, 65 | μmol/L | | - | 17,[26] 34 | 60, 110 | μg/dL | - | Copper (Cu) | 70 | 150 | μg/dL | | - | 11[27] | 24 | μmol/L | - | | 15 | 60 | mg/dL | | - | 1[28] | 4 | μmol/L | | - | Phosphate (HPO42−) | 0.8 | 1.5[29] | mmol/L | | - | - | Inorganic phosphorus (serum) | 1.0 | 1.5 | mmol/L | - | 3.0 | 4.5 | mg/dL | | - | - | Zinc (Zn) | 60,[30] 72[31] | 110, 130 | μg/dL | | - | 9.2,[32] 11 | 17, 20 | μmol/L | - | | 1.5, 1.7[33] | 2.0, 2.3 | mEq/L or mg/dL | | - | 0.6,[34] 0.7 | 0.82, 0.95 | mmol/L | - | |
---|
- Note: Although 'mEq' for mass and 'mEq/L' are sometimes used in the United States and elsewhere, they are not part of SI and are now considered redundant.
Acid–base and blood gases
If arterial/venous is not specified for an acid–base or blood gas value, then it generally refers to arterial, and not venous which otherwise is standard for other blood tests.
Acid–base and blood gases are among the few blood constituents that exhibit substantial difference between arterial and venous values.[5] Still, pH, bicarbonate and base excess show a high level of inter-method reliability between arterial and venous tests, so arterial and venous values are roughly equivalent for these.[35]
Test | Arterial/Venous | Lower limit | Upper limit | Unit | - | | Arterial | 7.34, 7.35 | 7.44, 7.45 | | - | Venous | 7.31[36] | 7.41 | | - | - | [H+] || rowspan=2|Arterial || 36 || 44 || nmol/L |- | 3.6[37] || 4.4 || ng/dL |- | Base excess || Arterial & venous || −3 || +3 || mEq/L |- |rowspan=4| Oxygen partial pressure (pO2) ||rowspan=2| Arterial pO2 || 10, 11 || 13, 14 || kPa |- | 75, 83 || 100, 105 || mmHg or torr |- |rowspan=2| Venous || 4.0 || 5.3 || kPa |- | 30 || 40 || mmHg or torr |- |rowspan=2| Oxygen saturation || Arterial || 94, 95,[38] 96 || 100 ||rowspan=2| % |- | Venous || colspan=2| Approximately 75 |- |rowspan=4| Carbon dioxide partial pressure (pCO2) ||rowspan=2| Arterial PaCO2 || 4.4, 4.7[39] || 5.9, 6.0 || kPa |- | 33, 35 || 44, 45 || mmHg or torr |- |rowspan=2| Venous || 5.5, || 6.8 || kPa |- | 41 || 51 || mmHg or torr |- |rowspan=2| Absolute content of carbon dioxide (CO2) ||rowspan=2| Arterial || 23 || 30 || mmol/L |- | 100[40] || 132 || mg/dL |- |rowspan=2| Bicarbonate (HCO3−) || rowspan=2| Arterial & venous || 18[41] || 23 || mmol/L |- | 110[42] || 140 || mg/dL |- |rowspan=2| Standard bicarbonate (SBCe) || rowspan=2| Arterial & venous || 21, 22 || 27, 28 || mmol/L or mEq/L |- | 134 || 170 || mg/dL |-|}Liver function
Test | Patient type | Lower limit | Upper limit | Unit | Comments | - | Total protein (TotPro) | | 60, 63 | 78, 82, 84 | g/L | | - | | | 35 | 48, 55 | g/L | | - | 3.5 | 4.8, 5.5 | U/L | - | 540[43] | 740 | μmol/L | - | | | 23 | 35 | g/L | | - | | | 1.7,[44] 2, 3.4, 5 | 17, 22, 25 | μmol/L | | - | 0.1, 0.2, 0.29 | 1.0, 1.3, 1.4[45] | mg/dL | | - | Direct/conjugated bilirubin | | 0.0 or N/A | 5, 7 | μmol/L | | - | 0 | 0.3, 0.4 | mg/dL | | - | Alanine transaminase (ALT/ALAT) | | 5, 7, 8[46] | 20, 21, 56 | U/L | Also called serum glutamic pyruvic transaminase (SGPT) | - | Female | 0.15 | 0.75 | μkat/L | - | Male | 0.15 | 1.1 | - | Aspartate transaminase (AST/ASAT) | Female | 6[47] | 34 | IU/L | Also called serum glutamic oxaloacetic transaminase (SGOT) | - | 0.25 | 0.60 | μkat/L | - | Male | 8 | 40 | IU/L | - | 0.25 | 0.75 | μkat/L | - | Alkaline phosphatase (ALP) | | 0.6 | 1.8 | μkat/L | | - | Female | 42[48] | 98 | U/L | | - | Male | 53 | 128 | | - | Gamma glutamyl transferase (GGT) | | 5, 8 | 40, 78 | U/L | | - | Female | | 0.63[49] | μkat/L | | - | Male | | 0.92 | μkat/L | | - | |
---|
Cardiac tests
Test | Patient type | Lower limit | Upper limit | Unit | Comments | - | Creatine kinase (CK) | Male | 24, 38, 60 | 174, 320 | U/L or ng/mL | | - | 0.42[50] | 1.5 | μkat/L | | - | Female | 24, 38, 96 | 140, 200 | U/L or ng/mL | | - | 0.17 | 1.17 | μkat/L | | - | | | 0 | 3, 3.8, 5 | ng/mL or μg/L | | - | | Female | 1[51] | 66 | ng/mL or μg/L | | - | Male | 17 | 106 | | - | Cardiac troponin T (low sensitive) | | | 0.1[52] | ng/mL | 99th percentile cutoff |
---|
Cardiac troponin I(high sensitive) | | | 0.03 | ng/mL | 99th percentile cutoff | Cardiac troponin T (high sensitive) | Male | | 0.022 | ng/mL | 99th percentile cutoff | Female | | 0.014 | ng/mL | 99th percentile cutoff | newborn/infants | | not established | | more than adults [53] [54] | |
Lipids
Test | Patient type | Lower limit | Upper limit | Unit | | - | Triglycerides | 10–39 years | 54 | 110 | mg/dL | < 100 mg/dL or 1.1 mmol/L | - | 0.61[58] | 1.2 | mmol/L | - | 40–59 years | 70 | 150 | mg/dL | - | 0.77 | 1.7 | mmol/L | - | > 60 years | 80 | 150 | mg/dL | - | 0.9 | 1.7 | mmol/L | - | | | 3.0,[59] 3.6 | 5.0, 6.5 | mmol/L | < 3.9 mmol/L | - | 120, 140 | 200, 250 | mg/dL | < 150 mg/dL | - | | Female | 1.0,[60] 1.2, 1.3 | 2.2 | mmol/L | > 1.0 or 1.6 mmol/L 40 or 60[61] mg/dL | - | 40,[62] 50[63] | 86 | mg/dL | - | HDL cholesterol | Male | 0.9 | 2.0 | mmol/L | - | 35 | 80 | mg/dL | - | LDL cholesterol (Not valid when triglycerides >5.0 mmol/L) | | 2.0, 2.4 | 3.0, 3.4 | mmol/L | < 2.5 mmol/L | - | 80, 94 | 120, 130 | mg/dL | < 100 mg/dL | - | LDL/HDL quotient | | n/a | 5 | (unitless) | | |
---|
Tumour markers
Test | Patient type | Cutoff | Unit | Comments | - | Alpha fetoprotein (AFP) | | 44 | ng/mL or μg/L | Hepatocellular carcinoma or testicular cancer | - | Beta human chorionic gonadotrophin (β-hCG) | In males and non-pregnant females | 5 | IU/L or mU/mL | choriocarcinoma | - | | | 40 | U/mL | Pancreatic cancer | - | | | 30,[64] 35[65] | kU/L or U/mL | | - | Carcinoembryonic antigen (CEA) | Non-smokers, 50 years | 3.4, 3.6[66] | μg/L | | - | Non-smokers, 70 years | 4.1 | | - | Smokers | 5[67] | | - | Prostate specific antigen (PSA) | 40–49 years | 1.2–2.9[68] | μg/L or ng/mL | | - | | 4.0–9.0 | - | 70–79 years, African-American | 7.7–13 | - | | | 3 | units/dL (Bodansky units) | | - | | | 5,[69] 15 | ng/L or pg/mL | Cutoff against medullary thyroid cancer More detailed cutoffs in Calcitonin article | |
---|
Endocrinology
Thyroid hormones
| 2.0, 3.0 | - | Infants | 1.3[73] | 19 | - | Free thyroxine (FT4) | Normal adult | 0.7,[74] 0.8 | 1.4, 1.5, 1.8[75] | ng/dL | - | 9, 10, 12[76] | 18,[77] 23 | pmol/L | - | Child/Adolescent 31 d – 18 y | 0.8 | 2.0 | ng/dL | - | 10 | 26 | pmol/L | - | Pregnant | 0.5 | 1.0 | ng/dL | - | 6.5 | 13 | pmol/L | - | Total thyroxine | | 4, 5.5 | 11, 12.3 | μg/dL | - | 60 | 140, 160 | nmol/L | - | Free triiodothyronine (FT3) | Normal adult | 0.2 | 0.5 | ng/dL | - | 3.1[78] | 7.7 | pmol/L | - | Children 2-16 y | 0.1[79] | 0.6 | ng/dL | - | 1.5 | 9.2 | pmol/L | - | | | 60, 75[80] | 175, 181 | ng/dL | - | 0.9, 1.1 | 2.5, 2.7 | nmol/L | - | Thyroxine-binding globulin (TBG) | | 12 | 30 | mg/L | - | Thyroglobulin (Tg) | | 1.5 | 30 | pmol/L | - | 1 | 20 | μg/L | - | |
---|
Sex hormones
The diagrams below take inter-cycle and inter-woman variability into account in displaying reference ranges for estradiol, progesterone, FSH and LH.
Other hormones
Test | Patient type | Lower limit | Upper limit | Unit | - | Adrenocorticotropic hormone (ACTH) | | 2.2[99] | 13.3 | pmol/L | - | 20 | 100 | pg/mL | - | | | 140[100] | 700 | nmol/L | - | 5[101] | 25 | μg/dL | - | Midnight | 80 | 350 | nmol/L | - | 2.9 | 13 | μg/dL | - | Growth hormone (fasting) | | 0 | 5 | ng/mL | - | Growth hormone (arginine stimulation) | | 7 | n/a | ng/mL | - | IGF-1 | Female, 20 yrs | 110[102] | 420 | ng/mL | - | Female, 75 yrs | 55 | 220 | - | Male, 20 yrs | 160 | 390 | - | Male, 75 yrs | 48 | 200 | - | Prolactin | Female | 71, 105 | 348, 548[103] | mIU/L | - | 3.4, 3.9 | 16.4, 20.3 | μg/L | - | Male | 58, 89 | 277, 365 | mIU/L | - | 2.7, 3.3 | 13.0, 13.5 | μg/L | - | Parathyroid hormone (PTH) | | 10,[104] 17[105] | 65, 70 | pg/mL | - | | 1.1, 1.8[106] | 6.9, 7.5 | pmol/L | - | | | 8,[107] 9 | 40, 80 | ng/mL | - | 20,[108] 23[109] | 95, 150 | nmol/L | - | | | 30,[110] 40[111] | 65, 100 | ng/mL | - | 85,[112] 100 | 120, 160 | nmol/L | - | | | 0.29,[113] 1.9 | 3.7[114] | ng/(mL·h) |
---|
| 3.3,[115] 21[116] | 41 | mcU/mL | - | Aldosterone | Adult | | 19, 34.0 | ng/dL | - | | 530, 940[117] | pmol/L | - | Aldosterone-to-renin ratio | Adult | | 13.1, 35.0[118] | ng/dL per ng/(mL·h) | - | | 360, 970 | pmol/liter per μg/(L·h) | |
Vitamins
Also including the vitamin B12)-related amino acid homocysteine.
Test | Patient type | Standard range | Optimal range | Unit | - | Lower limit | Upper limit | Lower limit | Upper limit | - | | | 30 | 65 | | | μg/dL | - | Vitamin B9 (Folic acid/Folate) – Serum | Age > 1 year | 3.0[119] | 16 | 5[120] | | ng/mL or μg/L | - | 6.8[121] | 36 | 11 | | nmol/L | - | Vitamin B9 (Folic acid/Folate) – Red blood cells | | 200 | 600 | | | ng/mL or μg/L | - | | 450 | 1400 | | | nmol/L | - | Pregnant | | | 400 | | ng/mL or μg/L | - | | | 900 | | nmol/L | - | Vitamin B12 (Cobalamin) | | 130,[122] 160[123] | 700, 950 | | | ng/L | - | | 100,[124] 120 | 520, 700 | | | pmol/L | - | Homocysteine | | 3.3,[125] 5.9 | 7.2, 15.3 | | 6.3 | μmol/L | - | | 45,[126] 80 | 100, 210 | | 85 | μg/dL | - | Vitamin C (Ascorbic acid) | | 0.4 | 1.5 | 0.9 | | mg/dL | - | 23[127] | 85 | 50 | | μmol/L | - | 25-hydroxycholecalciferol (a vitamin D) | | 8, 9 | 40, 80 | 30, 40 | 65, 100 | ng/mL | - | 20, 23 | 95, 150 | 85, 100 | 120, 160 | nmol/L | - | | | | | 28 | | μmol/L | - | | | 1.2 | | mg/dL | - | |
---|
Toxic Substances
Test | Limit type | Limit | Unit | - | | | < 20 or 40 | μg/dL | - | | | 0, 0.2,[128] 0.8 | ‰ or g/L | - | 17.4[129] | mmol/L | |
---|
Hematology
Red blood cells
These values (except Hemoglobin in plasma) are for total blood and not only blood plasma.
Test | Patient | Lower limit | Upper limit | Unit | Comments | - | Hemoglobin (Hb) | Male | 2.0,[130] 2.1[131] | 2.5, 2.7 | mmol/L | Higher in neonates, lower in children. | - | 130, 132, 135 | 162, 170, 175 | g/L | - | Female | 1.8, 1.9 | 2.3, 2.5 | mmol/L | Sex difference negligible until adulthood. | - | 120[132] | 150, 152, 160 | g/L | - | Hemoglobin subunits (sometimes displayed simply as "Hemoglobin") | Male | 8.0,[133] 8.4 | 10.0, 10.8 | mmol/L | 4 per hemoglobin molecule | - | Female | 7.2, 7.6 | 9.2, 10.0 | - | Hemoglobin in plasma | | 0.16 | 0.62 | μmol/L | Normally diminutive compared with inside red blood cells | - | | 1 | 4 | mg/dL | - | Glycated hemoglobin (HbA1c) | < 50 years | 3.6 | 5.0 | % of Hb | | - | > 50 years | 3.9 | 5.3 | - | | < 50 years | 0.35 | 1.9 | g/L | | - | > 50 years | 0.47 | 2.1 | - | Hematocrit (Hct) | Male | 0.39, 0.4, 0.41, 0.45 | 0.50, 0.52, 0.53, 0.62 | L/L | | - | Female | 0.35, 0.36, 0.37 | 0.46, 0.48 | L/L | | - | Child | 0.31 | 0.43 | L/L | | - | Mean corpuscular volume (MCV) | Male | 76, 82 | 100, 102 | fL | Cells are larger in neonates, though smaller in other children. | - | Female | 78 | 101 | fL | - | Red blood cell distribution width (RDW) | | 11.5 | 14.5 | % | | - | Mean cell hemoglobin (MCH) | | 0.39 | 0.54 | fmol/cell | | - | 25, 27 | 32, 33, 35 | pg/cell | - | Mean corpuscular hemoglobin concentration (MCHC) | | 4.8,[134] 5.0 | 5.4, 5.6 | mmol/L | | - | | 31, 32 | 35, 36 | g/dL or % | - | Erythrocytes/Red blood cells (RBC) | Male | 4.2, 4.3 | 5.7, 5.9, 6.2, 6.9 | x1012/L or million/mm3 | | - | Female | 3.5, 3.8, 3.9 | 5.1, 5.5 | | - | Infant/Child | 3.8 | 5.5 | | - | Reticulocytes | Adult | 26 | 130 | x109/L | | - | 0.5 | 1.5 | % of RBC | | - | Newborn | 1.1 | 4.5 | % of RBC | | - | Infant | 0.5 | 3.1 | % of RBC | | - | Immature reticulocyte fraction (IRF) | Adult | 1.6[135] | 12.1 | % of reticulocytes | | - | Reticulocyte hemoglobin equivalent | Adult | 30.0 | 37.6 | % | | - | 24.1[136] | 35.8 | pg | - | Immature platelet fraction (IPF) | Adult | 0.8 | 5.6 | % | | |
---|
White blood cells
These values are for total blood and not only blood plasma.
Test | Patient type | Lower limit | Upper limit | Unit | - | Rowspan=3 | White Blood Cell Count (WBC) | Adult | 3.5, 3.9,[137] 4.1, 4.5 | 9.0, 10.0, 10.9, 11 | - x109/L
- x103/mm3 or
- x103/μL
| - | Newborn | 9[138] | 30 | - | 1 year old | 6 | 18 | - | Neutrophil granulocytes (A.K.A. grans, polys, PMNs, or segs) | Adult | 1.3, 1.8, 2 | 5.4, 7, 8 | x109/L | - | 45–54 | 62, 74 | % of WBC | - | Newborn | 6 | 26 | x109/L | - | | Adult | | 0.7 | x109/L | - | 3 | 5 | % of WBC | - | Lymphocytes | Adult | 0.7, 1.0 | 3.5, 3.9, 4.8 | x109/L | - | 16–25 | 33, 45 | % of WBC | - | Newborn | 2 | 11 | x109/L | - | Monocytes | Adult | 0.1, 0.2[139] [140] | 0.8 | x109/L | - | 3, 4.0 | 7, 10 | % of WBC | - | Newborn | 0.4 | 3.1 | x109/L | - | Mononuclear leukocytes (Lymphocytes + monocytes) | Adult | 1.5 | 5 | x109/L | - | 20 | 35 | % of WBC | - | | Adult | 0.4,[141] 0.5 | 1.5, 1.8 | x109/L | - | Eosinophil granulocytes | Adult | 0.0, 0.04 | 0.44, 0.45, 0.5 | x109/L | - | 1 | 3, 7 | % of WBC | - | Newborn | 0.02 | 0.85 | x109/L | - | Basophil granulocytes | Adult | 40 | 100, 200, 900 | x106/L | - | 0.0 | 0.75, 2 | % of WBC | - | Newborn | | 0.64 | x109/L | |
---|
Coagulation
Test | Lower limit | Upper limit | Unit | Comments | - | Thrombocyte/Platelet count (Plt) | 140, 150 | 350, 400, 450 | x109/L or x1000/μL | | - | Mean platelet volume (MPV) | 7.2,[142] 7.4,[143] 7.5[144] | 10.4, 11.5, 11.7 | | | - | Prothrombin time (PT) | 10, 11, 12 | 13, 13.5, 14, 15 | s | PT reference varies between laboratory kits – INR is standardised | - | INR | 0.9 | 1.2 | | The INR is a corrected ratio of a patient's PT to normal | - | Activated partial thromboplastin time (APTT) | 18, 30 | 28, 42, 45 | s | | - | Thrombin clotting time (TCT) | 11 | 18 | s | | - | | 1.7, 2.0 | 3.6, 4.2 | g/L | | - | | 0.80 | 1.2 | kIU/L | | - | 0.15, 0.17[145] | 0.2, 0.39 | mg/mL | - | | 2 | 9 | minutes | | - | Viscosity | 1.5[146] | 1.72 | | | |
---|
Immunology
Acute phase proteins
Acute phase proteins are markers of inflammation.
Isotypes of antibodies
Test | Patient | Lower limit | Upper limit | Unit | - | | Adult | 70, 110[154] | 360, 560 | mg/dL | - | | 0.5 | 3.0 | - | | 0.01 | 0.04 | - | | 800 | 1800 | - | | 54 | 220 | - | |
---|
Autoantibodies
Autoantibodies are usually absent or very low, so instead of being given in standard reference ranges, the values usually denote where they are said to be present, or whether the test is a positive test. There may also be an equivocal interval, where it is uncertain whether there is a significantly increased level.
Test | Negative | Equivocal | Positive | Unit | - | anti-SS-A (Ro) | < 1.0[155] | n/a | ≥ 1.0 | Units (U) | - | anti-SS-B (La) | < 1.0[156] | n/a | ≥ 1.0 | - | | < 30.0[157] | 30.0–75.0 | > 75.0 | International Units per millilitre (IU/mL) | - | | < 8[158] | 8–10 | > 10 | Units per millilitre (U/mL) | - | | < 25 | n/a | > 25 | - | Cytoplasmic anti-neutrophil cytoplasmic antibodies (c-ANCA) | < 20 | 21–30 | > 30 | - | Perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) | < 5 | n/a | > 5 | - | Anti-mitochondrial antibodies (AMA) | < 0.1[159] | 0.1-0.9 | ≥ 1.0 | Units (U) | - | Rheumatoid factor (RF) | < 20 | 20–30 | > 30 | Units per millilitre (U/mL) | - | Antistreptolysin O titre (ASOT) in preschoolers | | | > 100 | - | ASOT at school age | > 250 | - | ASOT in adults | > 125 | |
---|
Test | Negative | Low/weak positive | Moderate positive | High/strong positive | Unit | - | Anti-phospholipid IgG | < 20 | 20–30 | 31–50 | > 51 | GPLU/mL | - | Anti-phospholipid IgM | < 1.5 | 1.5–2.5 | 2–9.9 | > 10 | MPL /mL | - | Anti-phospholipid IgA | < 10 | 10–20 | 21–30 | > 31 | arb U/mL | - | | < 20 | 20–39 | 40–59 | > 60 | EU | |
---|
Other immunology
Other enzymes and proteins
Test | Lower limit | Upper limit | Unit | Comments | - | | 60, 63 | 78, 82, 84 | g/L | | - | Lactate dehydrogenase (LDH) | 50 | 150 | U/L | | - | 0.4 | 1.7 | μmol/L | | - | 1.8 | 3.4 | μkat/L | < 70 years old | - | | 25, 30, 53 | 110, 120, 123, 125, 190 | U/L | | - | 0.15 | 1.1 | μkat/L | | - | 200[161] | 240 | nmol/L | | - | D-dimer | n/a | 500[162] | ng/mL | Higher in pregnant women[163] | - | 0.5 | mg/L | - | | 7, 10, 23 | 60, 150, 208 | U/L | | - | Angiotensin-converting enzyme (ACE) | 23 | 57 | U/L | | - | | | 3.0 | ng/mL | | - | Eosinophil cationic protein (ECP) | 2.3 | 16 | μg/L | | |
---|
Other electrolytes and metabolites
Electrolytes and metabolites:For iron and copper, some related proteins are also included.
Test | Patient type | Lower limit | Upper limit | Unit | Comments | - | | | 275, 280, 281 | 295, 296, 297 | mOsm/kg | Plasma weight excludes solutes | - | | | Slightly less than osmolality | mOsm/L | Plasma volume includes solutes | - | | | 3.0[164] | 7.0 | mmol/L | | - | 7 | 18, 21 | mg/dL | - | | | 0.18 | 0.48 | mmol/L | | - | Female | 2.0 | 7.0 | mg/dL | | - | Male | 2.1 | 8.5 | mg/dL | | - | | Male | 60, 68[165] | 90, 118 | μmol/L | | - | 0.7, 0.8[166] | 1.0, 1.3 | mg/dL | - | Female | 50, 68 | 90, 98 | μmol/L | - | 0.6, 0.8 | 1.0, 1.1 | mg/dL | - | BUN/Creatinine Ratio | | 5 | 35 | – | | - | Plasma glucose (fasting) | | 3.8, 4.0 | 6.0, 6.1 | mmol/L | See also glycated hemoglobin (in hematology) | - | 65, 70, 72[167] | 100, 110 | mg/dL | - | Full blood glucose (fasting) | | 3.3 | 5.6 | mmol/L | - | 60 | 100 | mg/dL | - | | | 3.9[168] | 7.8 | mmol/L | - | 70[169] | 140 | mg/dL | - | Lactate (Venous) | | 4.5 | 19.8 | mg/dL | | - | 0.5[170] | 2.2 | mmol/L | | - | Lactate (Arterial) | | 4.5 | 14.4 | mg/dL | | - | 0.5 | 1.6 | mmol/L | | - | | | 300 | 900 | μg/dL | | - | 34[171] | 102 | μmol/L | | - | Ketones | | | 1 | mg/dL | | - | | 0.1 | mmol/L | | |
---|
Medication
See also
External links
Further reading
- Rappoport . n. . Paik . P. . Oskotsky . B. . Tor . R. . Ziv . E. . Zaitlen . N. . Butte . A. . 4 November 2017 . Creating ethnicity-specific reference intervals for lab tests from EHR data . 10.1101/213892 .
Notes and References
- Web site: Reference Ranges and What They Mean. Lab Tests Online (USA). 22 June 2013. 28 August 2013. https://web.archive.org/web/20130828020717/http://labtestsonline.org/understanding/features/ref-ranges/start/6. dead.
- https://books.google.com/books?id=Je_pJfb2r0cC&pg=PA19 Page 19
- Bransky A, Larsson A, Aardal E, Ben-Yosef Y, Christenson RH. A Novel Approach to Hematology Testing at the Point of Care. . J Appl Lab Med . 2021 . 6 . 2 . 532–542 . 33274357 . 10.1093/jalm/jfaa186 . 7798949 .
- https://books.google.com/books?id=BfdighlyGiwC "Units of measurement"
- http://findarticles.com/p/articles/mi_m3230/is_4_32/ai_61893437/ "Arterial versus venous reference ranges"
- 10.1097/AOG.0b013e3181c2bde8. 19935037. Pregnancy and Laboratory Studies. Obstetrics & Gynecology. 114. 6. 1326–31. 2009. Abbassi-Ghanavati . M. . Greer . L. G. . Cunningham . F. G. . 24249021.
- Armbruster. David. Miller . The Joint Committee for Traceability in Laboratory Medicine (JCTLM): A Global Approach to Promote the Standardisation of Clinical Laboratory Test Results. The Clinical Biochemist Reviews. August 2007. 28. 3. 105–14. 1994110. 17909615.
- Sample Sizes for Prediction Intervals. William Q. Meeker & Gerald J. Hahn. 10.1080/00224065.1982.11978821. Journal of Quality Technology. 14. 1982. 4. 201–206 .
- https://www.uniprot.org/uniprot/P01189 PROOPIOMELANOCORTIN; NCBI / POMC
- Derived from molar values using molar mass of 22.99 g•mol−1
- Derived from molar values using molar mass of 39.10 g•mol−1
- Derived from molar values using molar mass of 35.45 g•mol−1
- Larsson L, Ohman S . Serum ionized calcium and corrected total calcium in borderline hyperparathyroidism . Clin. Chem. . 24 . 11 . 1962–65 . November 1978 . 709830 . 10.1093/clinchem/24.11.1962. free .
- Derived from molar values using molar mass of 40.08 g•mol−1
- Derived from mass values using molar mass of 40.08 g•mol−1
- Web site: Slon S . Serum Iron . 2006-09-22 . University of Illinois Medical Center . 2006-07-06 . dead . https://web.archive.org/web/20061028111833/http://uimc.discoveryhospital.com/main.php?t=enc&id=1456 . 2006-10-28 .
- http://www.dclmexico.com/ingles/hierro_sl.pdf Diagnostic Chemicals Limited > Serum Iron-SL Assay
- Derived from mass values using molar mass of 55.85 g•mol−1
- http://www.clinchem.org/cgi/reprint/45/1/131.pdf Table 1.
- Derived by dividing mass values with molar mass
- https://www.nlm.nih.gov/medlineplus/ency/article/003490.htm Ferritin
- Web site: Hemochromatosis Workup. Andrea Duchini. Medscape. 2016-07-14. Updated: Jan 02, 2016
- Derived from mass values using molar mass of 450,000 g•mol−1
- Mitchell ML, Filippone MD, Wozniak TF . Metastatic carcinomatous cirrhosis and hepatic hemosiderosis in a patient heterozygous for the H63D genotype . Arch. Pathol. Lab. Med. . 125 . 8 . 1084–87 . August 2001 . 11473464 . 10.5858/2001-125-1084-MCCAHH.
- Diaz J, Tornel PL, Martinez P . Reference intervals for blood ammonia in healthy subjects, determined by microdiffusion . Clin. Chem. . 41 . 7 . 1048 . July 1995 . 7600690 . 10.1093/clinchem/41.7.1048a. free .
- Derived from molar values using molar mass of 17.03 g/mol
- Derived from mass values using molar mass of 63.55 g•mol−1
- Derived from mass using molar mass of 151kDa
- Book: Walter F. Boron . Medical Physiology: A Cellular And Molecular Approaoch . Elsevier/Saunders . 2005. 978-1-4160-2328-9. 849.
- Web site: Archived copy . 2010-01-17 . dead . https://web.archive.org/web/20100307231954/http://www.dlolab.com/PDFs/DLO-OCTOBER-2008-LAB-UPDATE.pdf . 2010-03-07 .
- Derived from molar values using molar mass of 65.38 g/mol
- Derived from mass values using molar mass of 65.38 g/mol
- Derived from molar values using molar mass of 24.31 g/mol
- Derived from mass values using molar mass of 24.31 g/mol
- Middleton P, Kelly AM, Brown J, Robertson M . Agreements between arterial and central venous values for pH, bicarbonate, base excess, and lactate . Emerg Med J . 23 . 8 . 622–24 . August 2006 . 16858095 . 2564165 . 10.1136/emj.2006.035915 .
- http://www.brooksidepress.org/Products/OperationalMedicine/DATA/operationalmed/Lab/ABG_ArterialBloodGas.htm The Medical Education Division of the Brookside Associates / ABG (Arterial Blood Gas)
- Derived from molar values using molar mass of 1.01 g•mol−1
- http://www.merck.com/mmhe/appendixes/ap2/ap2b.html Merck Manuals > Common Medical Tests > Blood Tests
- Derived from mmHg values using 0.133322 kPa/mmHg
- Derived from molar values using molar mass of 44.010 g/mol
- http://www.bloodbook.com/ranges.html Blood Test Results – Normal Ranges
- Derived from molar values using molar mass of 61 g/mol
- Derived from mass using molecular weight of 65kD
- Derived from mass values using molar mass of 585g/mol
- Derived from molar values using molar mass of 585g/mol
- Last page of Book: Deepak A. Rao . Le, Tao . Bhushan, Vikas . First Aid for the USMLE Step 1 2008 (First Aid for the Usmle Step 1) . McGraw-Hill Medical . 2007 . 978-0-07-149868-5 . registration .
- http://www.gpnotebook.co.uk/simplepage.cfm?ID=322240579 GPnotebook > reference range (AST)
- Fachwörterbuch Kompakt Medizin E-D/D-E. Author: Fritz-Jürgen Nöhring. Edition 2. Publisher:Elsevier, Urban&FischerVerlag, 2004. . Length: 1288 pages
- Web site: Gamma-GT . Leistungsverzeichnis . Medizinisch-Diagnostische Institute . 20 November 2011 . dead . https://web.archive.org/web/20120425233448/http://www.mdi-labor.de/l_leistungsverzeichnis_detail.php?u_id=663&init=letter . 25 April 2012 .
- https://books.google.com/books?id=AUSIRcV_as0C&pg=PA585 Page 585
- http://www.medialabinc.net/muscle-keyword.aspx Muscle Information and Courses from MediaLab, Inc. > Cardiac Biomarkers
- Web site: Ashvarya Mangla. Troponins. 2017-07-24. medscape. Updated: Jan 14, 2015
- 2016-07-01. Plasma cardiac troponin I concentrations in healthy neonates, children and adolescents measured with a high sensitive immunoassay method: High sensitive troponin I in pediatric age. Clinica Chimica Acta. en. 458. 68–71. 10.1016/j.cca.2016.04.029. 27118089. 0009-8981. Caselli. C.. Cangemi. G.. Masotti. S.. Ragusa. R.. Gennai. I.. Del Ry. S.. Prontera. C.. Clerico. A..
- Baum. Hannsjörg. Hinze. Anika. Bartels. Peter. Neumeier. Dieter. 2004-12-01. Reference values for cardiac troponins T and I in healthy neonates. Clinical Biochemistry. en. 37. 12. 1079–82. 10.1016/j.clinbiochem.2004.08.003. 15589813. 0009-9120.
- Brenden CK, Hollander JE, Guss D, etal . Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study . American Heart Journal . 151 . 5 . 1006–11 . May 2006 . 16644322 . 10.1016/j.ahj.2005.10.017.
- Strunk A, Bhalla V, Clopton P, etal . Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study . The American Journal of Medicine . 119 . 1 . 69.e1–11 . January 2006 . 16431187 . 10.1016/j.amjmed.2005.04.029. free .
- https://books.google.com/books?id=AUSIRcV_as0C&pg=PA220 Page 220
- Derived from values in mg/dL to mmol/L, by dividing by 89, according to faqs.org: What are mg/dL and mmol/L? How to convert? Glucose? Cholesterol? Last Update July 21, 2009. Retrieved on July 21, 2009
- Derived from values in mg/dL to mmol/L, using molar mass of 386.65 g/mol
- http://www.rcpamanual.edu.au/sections/pathologytest.asp?s=33&i=450 Royal College of Pathologists of Australasia; Cholesterol (HDL and LDL) – plasma or serum
- http://www.americanheart.org/presenter.jhtml?identifier=183 What Your Cholesterol Levels Mean.
- Derived from values in mmol/L, using molar mass of 386.65 g/mol
- Web site: HDL Cholesterol: The Test. September 3, 2001. https://web.archive.org/web/20010903133121/http://www.labtestsonline.org/understanding/analytes/hdl/test.html. 2001-09-03.
- http://www.gpnotebook.co.uk/simplepage.cfm?ID=-100270014 GP Notebook > range (reference, ca-125)
- http://www.clinlabnavigator.com/Test-Interpretations/ca-125.html ClinLab Navigator > Test Interpretations > CA-125
- Bjerner J, Høgetveit A, Wold Akselberg K, etal . 12545738 . Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study . Scandinavian Journal of Clinical and Laboratory Investigation . 68. 8. 703–13 . June 2008 . 18609108 . 10.1080/00365510802126836 .
- http://www.medicinenet.com/carcinoembryonic_antigen/article.htm Carcinoembryonic Antigen(CEA)
- Luboldt. Hans-Joachim. Schindler. Joachim F.. Rübben. Herbert. Age-Specific Reference Ranges for Prostate-Specific Antigen as a Marker for Prostate Cancer. EAU-EBU Update Series. 5. 1. 2007. 38–48. 1871-2592. 10.1016/j.eeus.2006.10.003.
- Basuyau JP, Mallet E, Leroy M, Brunelle P . Reference intervals for serum calcitonin in men, women, and children . Clinical Chemistry . 50 . 10 . 1828–30 . October 2004 . 15388660 . 10.1373/clinchem.2003.026963. free .
- http://thyroid.about.com/od/gettestedanddiagnosed/a/tshtestwars.htm The TSH Reference Range Wars: What's "Normal?", Who is Wrong, Who is Right...
- http://www.aace.com/newsroom/press/2006/index.php?r=20060110 2006 Press releases: Thyroid Imbalance? Target Your Numbers
- http://thyroid.about.com/od/gettestedanddiagnosed/a/tshtestwars.htm The TSH Reference Range Wars: What's "Normal?", Who is Wrong, Who is Right...
- Web site: Demers. Laurence M.. Carole A. Spencer. LMPG: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. National Academy of Clinical Biochemistry (USA). 2002. 2007-04-13. 2008-11-20. https://web.archive.org/web/20081120130504/http://www.nacb.org/lmpg/thyroid_LMPG_PDF.stm. dead. – see Section 2. Pre-analytic factors
- http://labs.unchealthcare.org/labstestinfo/f_tests/free_t4.htm Free T4; Thyroxine, Free; T4, Free
- Derived from molar values using molar mass of 776.87 g/mol
- van der Watt G, Haarburger D, Berman P . Euthyroid patient with elevated serum free thyroxine . Clinical Chemistry . 54 . 7 . 1239–41 . July 2008 . 18593963 . 10.1373/clinchem.2007.101428. free .
- Derived from mass values using molar mass of 776.87 g/mol
- Derived from mass values using molar mass of 650.98 g/mol
- . Cioffi M, Gazzerro P, Vietri MT, etal . Serum concentration of free T3, free T4 and TSH in healthy children . Journal of Pediatric Endocrinology & Metabolism . 14 . 9 . 1635–39 . 2001 . 11795654 . 10.1515/jpem.2001.14.9.1635. 34910563 .
- http://www.thyroidmanager.org/chapter6/Ch-6b-2.htm Table 4: Typical reference ranges for serum assays
- Web site: Andrology Australia: Your Health > Low Testosterone > Diagnosis. 2008-11-28. 2012-02-17. https://web.archive.org/web/20120217051046/http://www.andrologyaustralia.org/pageContent.asp?pageCode=LOWTESTDIAG#LOWTESTDIAGNORM. dead.
- Derived from mass values using molar mass of 288.42g/mol
- Derived from molar values using molar mass of 288.42g/mol
- https://www.nlm.nih.gov/medlineplus/ency/article/003707.htm#Normal%20Values MedlinePlus > Testosterone
- Derived from mass values using molar mass of 330.46g/mol
- http://www.gpnotebook.co.uk/simplepage.cfm?ID=436600899 reference range (FSH)
- Values taken from day 1 after LH surge in: Stricker R, Eberhart R, Chevailler MC, Quinn FA, Bischof P, Stricker R . 524952 . Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer . Clinical Chemistry and Laboratory Medicine . 44 . 7 . 883–87 . 2006 . 16776638 . 10.1515/CCLM.2006.160.
- http://www.nyhq.org/Reference_Ranges& New York Hospital Queens > Services and Facilities > Patient Testing > Pathology > New York Hospital Queens Diagnostic Laboratories > Test Directory > Reference Ranges
- http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/8663 Mayo Medical Laboratories > Test ID: LH, Luteinizing Hormone (LH), Serum
- http://www.gpnotebook.co.uk/simplepage.cfm?ID=570818627&linkID=24801&cook=yes GPNotebook – reference range (oestradiol)
- Derived from molar values using molar mass of 272.38g/mol
- Total amount multiplied by 0.022 according to 2.2% presented in: Wu CH, Motohashi T, Abdel-Rahman HA, Flickinger GL, Mikhail G . Free and protein-bound plasma estradiol-17 beta during the menstrual cycle . J. Clin. Endocrinol. Metab. . 43 . 2 . 436–45 . August 1976 . 950372 . 10.1210/jcem-43-2-436.
- Derived from mass values using molar mass of 314.46 g/mol
- Bhattacharya Sudhindra Mohan (July/August 2005) Mid-luteal phase plasma progesterone levels in spontaneous and clomiphene citrate induced conception cycles J Obstet Gynecol India Vol. 55, No. 4 : July/August 2005 pp. 350–52
- http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/8493 Dehydroepiandrosterone Sulfate (DHEA-S), Serum
- http://www.mayomedicallaboratories.com/test-catalog/print.php?unit_code=91215 Unit Code 91215
- http://www.mayomedicallaboratories.com/test-catalog/print/89711 Antimullerian Hormone (AMH), Serum
- Derived from mass values using 140,000 g/mol, as given in:
- Hampl R, Šnajderová M, Mardešić T . Antimüllerian hormone (AMH) not only a marker for prediction of ovarian reserve . Physiological Research . 60 . 2 . 217–23 . 2011 . 21114374 . 10.33549/physiolres.932076 . free .
- Web site: Nieman . Lynnette K . Measurement of ACTH, CRH, and other hypothalamic and pituitary peptides . www.uptodate.com . UpToDate . 25 June 2021 . 29 September 2019.
- http://www.goodhope.org.uk/departments/pathweb/refranges.htm Biochemistry Reference Ranges at Good Hope Hospital
- Derived from molar values using molar mass of 362 g/mol
- Friedrich N, Alte D, Völzke H, etal . Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP) . Growth Hormone & IGF Research . 18 . 3 . 228–37 . June 2008 . 17997337 . 10.1016/j.ghir.2007.09.005.
- Taken from the assay method giving the lowest and highest estimate, respectively, from Table 2 in: Beltran L, Fahie-Wilson MN, McKenna TJ, Kavanagh L, Smith TP . Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms . Clinical Chemistry . 54 . 10 . 1673–81 . October 2008 . 18719199 . 10.1373/clinchem.2008.105312. free .
- Derived from molar values using molar mass of 9.4 kDa
- https://www.ncbi.nlm.nih.gov/pmc/articles/mid/NIHMS10653/table/T2/ Table 2
- Derived from mass values using molar mass of 9.4 kDa
- Derived from molar values using molar mass 400.6 g/mol
- Book: Bender, David A. . Vitamin D . Nutritional biochemistry of the vitamins . Cambridge University Press . Cambridge . 2003 . 978-0-521-80388-5 . https://books.google.com/books?id=pxEJNs0IUo4C. Retrieved December 10, 2008 through Google Book Search.
- Bischoff-Ferrari HA, Dietrich T, Orav EJ, etal . Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or 60 y . The American Journal of Clinical Nutrition . 80 . 3 . 752–58 . September 2004 . 15321818 . 10.1093/ajcn/80.3.752. free .
- Reusch J, Ackermann H, Badenhoop K . Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population . Horm. Metab. Res. . 41 . 5 . 402–07 . May 2009 . 19241329 . 10.1055/s-0028-1128131 . 260166796 .
- Vasquez A, Cannell J . Calcium and vitamin D in preventing fractures: data are not sufficient to show inefficacy . BMJ . 331 . 7508 . 108–09; author reply 109 . July 2005 . 16002891 . 558659 . 10.1136/bmj.331.7508.108-b.
- http://www.adeeva.com/resources/bloodtestscomplete.html Adëeva Nutritionals Canada > Optimal blood test values
- Converted from values in mcU/mL by dividing with a factor of 11.2 mcU/mL per ng/(mL*hour), as given in:
Washington, Department of Laboratory Medicine. Retrieved Mars 2011
- Pratt RE, Flynn JA, Hobart PM, Paul M, Dzau VJ . Different secretory pathways of renin from mouse cells transfected with the human renin gene . The Journal of Biological Chemistry . 263 . 7 . 3137–41 . March 1988 . 10.1016/S0021-9258(18)69046-5 . 2893797 . free .
- http://depts.washington.edu/labweb/referencelab/print/endo.pdf New Assays for Aldosterone, Renin and Parathyroid Hormone
- Converted from values in ng/(mL*hour) by multiplying with a factor of 11.2 mcU/mL per ng/(mL*hour), as given in:
Washington, Department of Laboratory Medicine. Retrieved Mars 2011
- Converted from mass values using molar mass of 360.44 g/mol
- Tiu SC, Choi CH, Shek CC, etal . The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling . The Journal of Clinical Endocrinology and Metabolism . 90 . 1 . 72–78 . January 2005 . 15483077 . 10.1210/jc.2004-1149. 10.1.1.117.5182 .
- http://www.cmft.nhs.uk/directorates/labmedicine/USERGUIDE/pdfs/Haem%20-%20Coagulation%20Ref%20Ranges.pdf Central Manchester University Hospitals / Reference ranges
- http://www.hosp.uky.edu/Clinlab/report.pdf University of Kentucky Chandler Medical Center > Clinical Lab Reference Range Guide
- Derived from mass values using molar mass of 441 mol−1
- http://www.gpnotebook.co.uk/simplepage.cfm?ID=-2087059389&linkID=35554&cook=no GPnotebook > B12
- Derived form molar values using molar mass of 1355g/mol
- Derived from mass values using molar mass of 1355g/mol
- Web site: Homocysteine. www.thedoctorsdoctor.com.
- Derived from molar values using molar massof 135 g/mol
- Derived from mass values using molar mass of 176 grams per mol
- For Driving under the influence by country, see Drunk driving law by country
- Derived from mass values using molar mass of 46g/mol
- Derived from mass values using 64,500 g/mol. This molar mass was taken from: Van Beekvelt MC, Colier WN, Wevers RA, Van Engelen BG . 15468862 . Performance of near-infrared spectroscopy in measuring local O2 consumption and blood flow in skeletal muscle . J Appl Physiol . 90 . 2 . 511–19 . 2001 . 11160049. 10.1152/jappl.2001.90.2.511 .
- http://musom.marshall.edu/usmle/usmlelabvalues.htm Normal Lab Values
- Reference range list from Uppsala University Hospital ("Laborationslista"). Artnr 40284 Sj74a. Issued on April 22, 2008
- molar concentration as given for hemoglobin above, but multiplied by 4, according to: Lodemann P, Schorer G, Frey BM . 3091357 . Wrong molar hemoglobin reference values-a longstanding error that should be corrected . Annals of Hematology . 89 . 2 . 209 . February 2010 . 19609525 . 10.1007/s00277-009-0791-x. free .
- Derived from mass concentration, using molar mass of 64,458 g/mol. This molar mass was taken from: Van Beekvelt MC, Colier WN, Wevers RA, Van Engelen BG . 15468862 . Performance of near-infrared spectroscopy in measuring local O2 consumption and blood flow in skeletal muscle . J Appl Physiol . 90 . 2 . 511–19 . 2001 . 11160049. 10.1152/jappl.2001.90.2.511 . . Subsequently, 1 g/dL = 0.1551 mmol/L
- Morkis IV, Farias MG, Scotti L. Determination of reference ranges for immature platelet and reticulocyte fractions and reticulocyte hemoglobin equivalent. . Rev Bras Hematol Hemoter . 2016 . 38 . 4 . 310–313 . 27863758 . 10.1016/j.bjhh.2016.07.001 . 5119661 .
- Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. . Clinical and Laboratory Haematology . 2006 . 28 . 5 . 303–8 . 16999719 . 10.1111/j.1365-2257.2006.00812.x . 1618805 .
- http://www.lymphomation.org/CBC-blood-counts.htm lymphomation.org > Tests & Imaging > Labs > Complete Blood Count
- Book: McClatchey, Kenneth D.. Clinical Laboratory Medicine. November 28, 2002. Lippincott Williams & Wilkins. 9780683307511. Google Books.
- http://www.termedia.pl/magazine.php?magazine_id=10&article_id=6801&magazine_subpage=ABSTRACT "Determination of monocyte count by hematological analyzers, manual method and flow cytometry in Polish population"
- http://www.gpnotebook.co.uk/simplepage.cfm?ID=-637140985 gpnotebook.co.uk > blood constituents (reference range)
- http://pathcuric1.swmed.edu/PathDemo/nrrt.htm Normal Reference Range Table
- Demirin H, Ozhan H, Ucgun T, Celer A, Bulur S, Cil H, Gunes C, Yildirim HA . Normal range of mean platelet volume in healthy subjects: Insight from a large epidemiologic study . Thromb. Res. . 128 . 4 . 358–60 . 2011 . 21620440 . 10.1016/j.thromres.2011.05.007 .
- http://www.labcareplus.org/docs/REFERENCE_RANGES.pdf Normal Values: RBC, Hgb, Hct, Indices, RDW, Platelets, and MPV (Conventional Units)
- Lozano M, Narváez J, Faúndez A, Mazzara R, Cid J, Jou JM, Marín JL, Ordinas A . [Platelet count and mean platelet volume in the Spanish population] . es. Med Clin (Barc) . 110 . 20 . 774–77 . 1998 . 9666418 .
- http://mghlabtest.partners.org/coagbook/co000300.htm Antithrombin CO000300
- Web site: Home . pathology.bsuh.nhs.uk . November 20, 2009.
- Böttiger LE, Svedberg CA . Normal erythrocyte sedimentation rate and age . Br Med J . 2 . 5544 . 85–87 . 1967 . 6020854 . 10.1136/bmj.2.5544.85. 1841240.
- Miller A, Green M, Robinson D . Simple rule for calculating normal erythrocyte sedimentation rate . British Medical Journal . 286 . 6361 . 266 . January 1983 . 6402065 . 1546487 . 10.1136/bmj.286.6361.266.
- http://iadr.confex.com/iadr/2008Toronto/techprogram/abstract_106289.htm 2730 Serum C-Reactive Protein values in Diabetics with Periodontal Disease
- Sipahi T, Kara C, Tavil B, Inci A, Oksal A . Alpha-1 antitrypsin deficiency: an overlooked cause of late hemorrhagic disease of the newborn . Journal of Pediatric Hematology/Oncology . 25 . 3 . 274–75 . March 2003 . 12621252 . 10.1097/00043426-200303000-00019.
- Derived from mass values using molar mass of 44324.5 g/mol
- Derived from molar values using molar mass of 44324.5 g/mol
- Web site: Procalcitonin, Serum . . 2015-03-01.
- http://www.ascls.org/labtesting/labchem.asp The Society for American Clinical Laboratory Science > Chemistry Tests > Immunoglobulins
- Web site: SSA – Clinical: SS-A/Ro Antibodies, IgG, Serum . www.mayocliniclabs.com . Mayo Clinic Laboratories . 2 July 2020.
- Web site: SSB – Clinical: SS-B/La Antibodies, IgG, Serum . www.mayocliniclabs.com . Mayo Clinic Laboratories . 2 July 2020.
- Web site: ADNA – Clinical: DNA Double-Stranded Antibodies, IgG, Serum . www.mayocliniclabs.com . Mayo Clinic Laboratories . 2 July 2020.
- http://www.chronolab.com/rheumatic/range.htm chronolab.com > Autoantibodies associated with rheumatic diseases > Reference ranges
- Web site: AMA – Clinical: Mitochondrial Antibodies (M2), Serum . www.mayocliniclabs.com . Mayo Clinic Laboratories . 2 July 2020.
- Rajkumar SV, Kyle RA, Therneau TM . Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance . Blood . 106 . 3 . 812–17 . August 2005 . 15855274 . 1895159 . 10.1182/blood-2005-03-1038 . etal .
- Derived from mass using molar mass of 25,106 g/mol
- Ageno W, Finazzi S, Steidl L, etal . Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes . Archives of Internal Medicine . 162 . 22 . 2589–93 . 2002 . 12456231 . 10.1001/archinte.162.22.2589. 2434/51239 . free .
- Kline JA, Williams GW, Hernandez-Nino J . D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed . Clinical Chemistry . 51 . 5 . 825–29 . May 2005 . 15764641 . 10.1373/clinchem.2004.044883. free .
- Gardner MD, Scott R . Age- and sex-related reference ranges for eight plasma constituents derived from randomly selected adults in a Scottish new town . Journal of Clinical Pathology . 33 . 4 . 380–85 . April 1980 . 7400337 . 1146084 . 10.1136/jcp.33.4.380.
- Finney H, Newman DJ, Price CP . 35866310 . Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance . Annals of Clinical Biochemistry . 37 . 1 . 49–59 . January 2000 . 10672373 . 10.1258/0004563001901524. free .
- Derived from molar values by multiplying with the molar mass of 113.118 g/mol, and divided by 10.000 to adapt from μg/L to mg/dL
- Derived from molar values using molar mass of 180g/mol
- Derived from mass values using molar mass of 180g/mol
- Web site: Diabetes – Prevention. Cleveland Clinic. 2016-06-23. Last revised 1/15/2013
- Derived from mass values using molar mass of 90.08 g/mol
- Derived from mass values using molar mass of 88.06 g/mol
- https://books.google.com/books?id=BfdighlyGiwC&pg=PA700 Page 700
- The UK Electronic Medical Compendium recommends 0.4–0.8 mmol/L plasma lithium level in adults for prophylaxis of recurrent affective bipolar manic-depressive illness Camcolit 250 mg Lithium Carbonate Revision 2 December 2010, Retrieved 5 May 2011
- Amdisen A. . Clinical and serum level monitoring in lithium therapy and lithium intoxication. J. Anal. Toxicol. . 2. 5. 193–202. 1978. 10.1093/jat/2.5.193.
- R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 8th edition, Biomedical Publications, Foster City, CA, 2008, pp. 851–54.
- One study (Solomon . D.. Ristow . W.. Keller . M.. Kane . J.. Gelenberg . A.. Rosenbaum . J.. Warshaw . M.. Serum lithium levels and psychosocial function in patients with bipolar I disorder. The American Journal of Psychiatry. 153. 10. 1301–07. 1996. 8831438 . 10.1176/ajp.153.10.1301.) concluded a "low" dose of 0.4–0.6 mmol/L serum lithium treatment for patients with bipolar 1 disorder had less side effects, but a higher rate of relapse, than a "standard" dose of 0.8–1.0 mmol/L. However, a reanalysis of the same experimental data (Perlis . R.. Sachs . G.. Lafer . B.. Otto . M.. Faraone . S.. Kane . J.. Rosenbaum . J.. 12103424. Effect of abrupt change from standard to low serum levels of lithium: A reanalysis of double-blind lithium maintenance data. The American Journal of Psychiatry. 159. 7. 1155–59. 2002. 12091193 . 10.1176/appi.ajp.159.7.1155.) concluded the higher rate of relapse for the "low" dose was due to abrupt changes in the lithium serum levels
- Book: Rosen's Emergency Medicine – Concepts and Clinical Practice. John Marx . Ron Walls . Robert Hockberger . Elsevier Health Sciences. 2013. 9781455749874.